Antithrombin III progressive function: a biochemical analysis

Area of Science:

• Biochemistry
• Protein purification

Background:

• Antithrombin III (AT III) is a crucial protein regulating blood coagulation.
• Understanding AT III purification and activity is vital for thrombosis research.

Purpose of the Study:

• To isolate and characterize antithrombin III (AT III) using distinct purification methods.
• To investigate the relationship between AT III aggregation and its heparin cofactor and progressive antithrombin activities.

Main Methods:

• Isolation of AT III using polyethylene glycol (PEG) precipitation followed by heparin-affinity chromatography or Sephacryl S-200 gel filtration.
• Assay of AT III antigen and progressive antithrombin activity using specific antisera and thrombin inhibition assays.
• Analysis of protein fractions using two-dimensional immunoelectrophoresis (2-DIE) in the presence of heparin.

Main Results:

• Two purification procedures yielded AT III with heparin cofactor activity.
• PEG precipitate and Sephacryl S-200 purified AT III fractions exhibited significant progressive antithrombin activity, potentiated by EDTA.
• AT III purified via heparin-affinity chromatography showed reduced progressive activity.
• Two-dimensional immunoelectrophoresis revealed differences in AT III forms, with Sephacryl-purified AT III showing a slow-moving component associated with progressive activity.

Conclusions:

• Polyethylene glycol (PEG) precipitation likely induces aggregation of antithrombin III (AT III).
• The formation and dissolution of AT III aggregates are associated with its progressive antithrombin activity.
• Different purification methods yield AT III with varying functional properties, highlighting the importance of purification strategies.